control group :Conventional treatment
Sponsors
Xiangyang 1st People's Hospital, Guangzhou reborn health management consultation co., LTD, Reproductive Hospital Affiliated to Shandong University, Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine, Affiliated Hospital of Hangzhou Normal University
Conditions
Carotid atherosclerotic plaque formationCoronary heart disease combined with diabetic nephropathyIVF-ET in patients with diminished ovarian reserveNovel Coronavirus Pneumonia (COVID-19)novel coronavirus pneumonia (COVID-19)
Early Phase 1
Withdraw Safety and efficacy of umbilical cord blood mononuclear cells conditioned medium in the treatment of severe and critically novel coronavirus pneumonia (COVID-19): a randomized controlled trial
Active, not recruitingChiCTR2000029569
Start: 2020-02-05Updated: 2020-09-28
Cancelled by the investigator Clinical Study for Cord Blood Mesenchymal Stem Cells in the Treatment of Acute Novel Coronavirus Pneumonia (COVID-19)
Active, not recruitingChiCTR2000029816
Start: 2020-02-20Updated: 2020-03-16
Phase 4
The effect and mechanism of Zishen Yutai Pill on IVF-ET in patients with diminished ovarian reserve
RecruitingITMCTR2200005713
Start: 2020-01-01Updated: 2023-02-20
The effect and mechanism of Zishen Yutai Pill on IVF-ET in patients with diminished ovarian reserve
RecruitingChiCTR2100048441
Start: 2020-01-01Updated: 2022-03-21
Clinical Study on the Effectiveness and Safety of Guanxinning Tablets on Coronary Heart Disease Complicated with Diabetic Nephropathy
Active, not recruitingITMCTR2100005416
Start: 2021-12-20Updated: 2023-02-20
Evaluation of the clinical efficacy of Guanxinning tablets in the treatment of patients with carotid atherosclerotic plaque
Active, not recruitingITMCTR2100005440
Start: 2021-12-21Updated: 2023-02-20
Evaluation of the clinical efficacy of Guanxinning tablets in the treatment of patients with carotid atherosclerotic plaque
Active, not recruitingChiCTR2100054694
Start: 2021-12-21Updated: 2022-12-05